Clinical Trial Update: Ondansetron for the Management of Atrial Fibrillation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial at Indiana University is investigating the use of ondansetron for the management of atrial fibrillation and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Ondansetron (ondansetron)

Snippet

Sponsor: Indiana University | Conditions: Atrial Fibrillation | Phase 4 | Status: RECRUITING